A group a Streptococcus ADP-ribosyltransferase toxin stimulates a protective interleukin 1β-dependent macrophage immune response

mBio

Volumn 6, Issue 2, 2015, Pages

  Lin, Ann E ^a   Beasley, Federico C ^a   Keller, Nadia ^a   Hollands, Andrew ^a   Urbano, Rodolfo ^a   Troemel, Emily R ^b   Hoffman, Hal M ^a,c,e   Nizet, Victor ^a,d,e  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^e RADY CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS INDUCING FACTOR; BACTERIAL TOXIN; CRYOPYRIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PSEUDOMONAS EXOTOXIN A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY TITER; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL GENE; BACTERIAL STRAIN; CELL DEATH; CONTROLLED STUDY; DEFENSE MECHANISM; DISEASE COURSE; FEMALE; GROWTH INHIBITION; IMMUNE RESPONSE; IN VITRO STUDY; INNATE IMMUNITY; MACROPHAGE; MOUSE; NECROTIZING FASCIITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SEPTICEMIA; SPYA GENE; STREPTOCOCCUS GROUP A; UPREGULATION; ANIMAL; CELL SURVIVAL; DISEASE MODEL; ENZYMOLOGY; GENE DELETION; GENETICS; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES; VIRULENCE;

BACTERIA (MICROORGANISMS); PSEUDOMONAS; STREPTOCOCCUS SP. 'GROUP A';

ADP RIBOSE TRANSFERASES; ANIMALS; CELL SURVIVAL; DISEASE MODELS, ANIMAL; GENE DELETION; INTERLEUKIN-1BETA; MACROPHAGES; MICE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; VIRULENCE;

EID: 84929497784     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.00133-15     Document Type: Article

References (48)

1. Carapetis JR, Steer AC, Mulholland EK, Weber M. 2005. The global burden of group A streptococcal diseases. Lancet Infect Dis 5:685-694. http://dx.doi.org/10.1016/S1473-3099(05)70267-X.
2. Aziz RK, Kotb M. 2008. Rise and persistence of global M1T1 clone of Streptococcus pyogenes. Emerg Infect Dis 14:1511-1517. http://dx.doi.org/10.3201/eid1410.071660.
3. Sumby P, Whitney AR, Graviss EA, DeLeo FR, Musser JM. 2006. Genome-wide analysis of group A streptococci reveals a mutation that modulates global phenotype and disease specificity. PLoS Pathog 2:e5. http://dx.doi.org/10.1371/journal.ppat.0020005.
4. Cole JN, Barnett TC, Nizet V, Walker MJ. 2011. Molecular insight into invasive group A streptococcal disease. Nat Rev Microbiol 9:724-736. http://dx.doi.org/10.1038/nrmicro2648.
5. Walker MJ, Hollands A, Sanderson-Smith ML, Cole JN, Kirk JK, Henningham A, McArthur JD, Dinkla K, Aziz RK, Kansal RG, Simpson AJ, Buchanan JT, Chhatwal GS, Kotb M, Nizet V. 2007. DNase Sda1 provides selection pressure for a switch to invasive group A streptococcal infection. Nat Med 13:981-985. http://dx.doi.org/10.1038/nm1612.
6. Cole JN, Pence MA, von Kockritz-Blickwede M, Hollands A, Gallo RL, Walker MJ, Nizet V. 2010. M protein and hyaluronic acid capsule are essential for in vivo selection of covRS mutations characteristic of invasive serotype M1T1 group A streptococcus. mBio 1:e00191-10. http://dx.doi.org/10.1128/mBio.00191-10.
7. Maamary PG, Sanderson-Smith ML, Aziz RK, Hollands A, Cole JN, McKay FC, McArthur JD, Kirk JK, Cork AJ, Keefe RJ, Kansal RG, Sun H, Taylor WL, Chhatwal GS, Ginsburg D, Nizet V, Kotb M, Walker MJ. 2010. Parameters governing invasive disease propensity of non-M1 serotype group A streptococci. J Innate Immun 2:596-606. http://dx.doi.org/10.1159/000317640.
8. Coye LH, Collins CM. 2004. Identification of SpyA, a novel ADPribosyltransferase of Streptococcus pyogenes. Mol Microbiol 54:89-98. http://dx.doi.org/10.1111/j.1365-2958.2004.04262.x.
9. Korotkova N, Hoff JS, Becker DM, Quinn JK, Icenogle LM, Moseley SL. 2012. SpyA is a membrane-bound ADP-ribosyltransferase of Streptococcus pyogenes which modifies a streptococcal peptide, SpyB. Mol Microbiol 83:936-952. http://dx.doi.org/10.1111/j.1365-2958.2012.07979.x.
10. Hoff JS, DeWald M, Moseley SL, Collins CM, Voyich JM. 2011. SpyA, a C3-like ADP-ribosyltransferase, contributes to virulence in a mouse subcutaneous model of Streptococcus pyogenes infection. Infect Immun 79: 2404-2411. http://dx.doi.org/10.1128/IAI.01191-10.
11. Deng Q, Barbieri JT. 2008. Molecular mechanisms of the cytotoxicity of ADP-ribosylating toxins. Annu Rev Microbiol 62:271-288. http://dx.doi.org/10.1146/annurev.micro.62.081307.162848.
12. Icenogle LM, Hengel SM, Coye LH, Streifel A, Collins CM, Goodlett DR, Moseley SL. 2012. Molecular and biological characterization of streptococcal SpyA-mediated ADP-ribosylation of intermediate filament protein vimentin. J Biol Chem 287:21481-21491. http://dx.doi.org/10.1074/jbc.M112.370791.
13. Franchi L, Muñoz-Planillo R, Núñez G. 2012. Sensing and reacting to microbes through the inflammasomes. Nat Immunol 13:325-332. http://dx.doi.org/10.1038/ni.2231.
14. Hagar JA, Miao EA. 2014. Detection of cytosolic bacteria by inflammatory caspases. Curr Opin Microbiol 17:61-66. http://dx.doi.org/10.1016/j.mib.2013.11.008.
15. Von Moltke J, Ayres JS, Kofoed EM, Chavarría-Smith J, Vance RE. 2013. Recognition of bacteria by inflammasomes. Annu Rev Immunol 31:73-106. http://dx.doi.org/10.1146/annurev-immunol-032712-095944.
16. Bergsbaken T, Fink SL, Cookson BT. 2009. Pyroptosis: host cell death and inflammation. Nat Rev Microbiol 7:99-109. http://dx.doi.org/10.1038/nrmicro2070.
17. Ng TM, Kortmann J, Monack DM. 2013. Policing the cytosol— bacterial-sensing inflammasome receptors and pathways. Curr Opin Immunol 25:34-39. http://dx.doi.org/10.1016/j.coi.2012.11.009.
18. Jayaraman P, Sada-Ovalle I, Nishimura T, Anderson AC, Kuchroo VK, Remold HG, Behar SM. 2013. IL-1beta promotes antimicrobial immunity in macrophages by regulating TNFR signaling and caspase-3 activation. J Immunol 190:4196-4204. http://dx.doi.org/10.4049/jimmunol.1202688.
19. Netea MG, Simon A, van de Veerdonk F, Kullberg BJ, Van der Meer JW, Joosten LA. 2010. IL-1beta processing in host defense: beyond the inflammasomes. PLoS Pathog 6:e1000661. http://dx.doi.org/10.1371/journal.ppat.1000661.
20. Dinarello CA. 1996. Biologic basis for interleukin-1 in disease. Blood 87:2095-2147.
21. Martinon F, Tschopp J. 2007. Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ 14: 10-22. http://dx.doi.org/10.1038/sj.cdd.4402038.
22. Henry T, Monack DM. 2007. Activation of the inflammasome upon Francisella tularensis infection: interplay of innate immune pathways and virulence factors. Cell Microbiol 9:2543-2551. http://dx.doi.org/10.1111/j.1462-5822.2007.01022.x.
23. Ren T, Zamboni DS, Roy CR, Dietrich WF, Vance RE. 2006. Flagellindeficient Legionella mutants evade caspase-1- and Naip5-mediated macrophage immunity. PLoS Pathog 2:e18. http://dx.doi.org/10.1371/journal.ppat.0020018.
24. Harder J, Franchi L, Muñoz-Planillo R, Park JH, Reimer T, Núñez G. 2009. Activation of the Nlrp3 inflammasome by Streptococcus pyogenes requires streptolysin O and NF-kappa B activation but proceeds independently of TLR signaling and P2X7 receptor. J Immunol 183:5823-5829. http://dx.doi.org/10.4049/jimmunol.0900444.
25. Kansal RG, McGeer A, Low DE, Norrby-Teglund A, Kotb M. 2000. Inverse relation between disease severity and expression of the streptococcal cysteine protease, SpeB, among clonal M1T1 isolates recovered from invasive group A streptococcal infection cases. Infect Immun 68: 6362-6369. http://dx.doi.org/10.1128/IAI.68.11.6362-6369.2000.
26. Aachoui Y, Sagulenko V, Miao EA, Stacey KJ. 2013. Inflammasomemediated pyroptotic and apoptotic cell death, and defense against infection. Curr Opin Microbiol 16:319-326. http://dx.doi.org/10.1016/j.mib.2013.04.004.
27. Zheng Y, Lilo S, Mena P, Bliska JB. 2012. YopJ-induced caspase-1 activation in Yersinia-infected macrophages: independent of apoptosis, linked to necrosis, dispensable for innate host defense. PLoS One 7:e36019. http://dx.doi.org/10.1371/journal.pone.0036019.
28. Pazyar N, Feily A, Yaghoobi R. 2012. An overview of interleukin-1 receptor antagonist, anakinra, in the treatment of cutaneous diseases. Curr Clin Pharmacol 7:271-275. http://dx.doi.org/10.2174/157488412803305821.
29. Iglewski BH, Liu PV, Kabat D. 1977. Mechanism of action of Pseudomonas aeruginosa exotoxin A: adenosine diphosphate-ribosylation of mammalian elongation factor 2 in vitro and in vivo. Infect Immun 15:138-144.
30. Jenkins CE, Swiatoniowski A, Issekutz AC, Lin TJ. 2004. Pseudomonas aeruginosa exotoxin A induces human mast cell apoptosis by a caspase-8 and -3-dependent mechanism. J Biol Chem 279:37201-37207. http://dx.doi.org/10.1074/jbc.M405594200.
31. Mühlen KA, Schümann J, Wittke F, Stenger S, Van Rooijen N, Van Kaer L, Tiegs G. 2004. NK cells, but not NKT cells, are involved in Pseudomonas aeruginosa exotoxin A-induced hepatotoxicity in mice. J Immunol 172:3034-3041. http://dx.doi.org/10.4049/jimmunol.172.5.3034.
32. Lima-Junior DS, Costa DL, Carregaro V, Cunha LD, Silva AL, Mineo TW, Gutierrez FR, Bellio M, Bortoluci KR, Flavell RA, Bozza MT, Silva JS, Zamboni DS. 2013. Inflammasome-derived IL-1beta production induces nitric oxide-mediated resistance to Leishmania. Nat Med 19: 909-915. http://dx.doi.org/10.1038/nm.3221.
33. Dockrell DH, Marriott HM, Prince LR, Ridger VC, Ince PG, Hellewell PG, Whyte MK. 2003. Alveolar macrophage apoptosis contributes to pneumococcal clearance in a resolving model of pulmonary infection. J Immunol 171:5380-5388. http://dx.doi.org/10.4049/jimmunol.171.10.5380.
34. Ali F, Lee ME, Iannelli F, Pozzi G, Mitchell TJ, Read RC, Dockrell DH. 2003. Streptococcus pneumoniae-associated human macrophage apoptosis after bacterial internalization via complement and Fcgamma receptors correlates with intracellular bacterial load. J Infect Dis 188:1119-1131. http://dx.doi.org/10.1086/378675.
35. Kobayashi SD, Braughton KR, Whitney AR, Voyich JM, Schwan TG, Musser JM, DeLeo FR. 2003. Bacterial pathogens modulate an apoptosis differentiation program in human neutrophils. Proc Natl Acad Sci U S A 100:10948-10953. http://dx.doi.org/10.1073/pnas.1833375100.
36. Stecher B, Robbiani R, Walker AW, Westendorf AM, Barthel M, Kremer M, Chaffron S, Macpherson AJ, Buer J, Parkhill J, Dougan G, von Mering C, Hardt WD. 2007. Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol 5:2177-2189. http://dx.doi.org/10.1371/journal.pbio.0050244.
37. Winter SE, Thiennimitr P, Winter MG, Butler BP, Huseby DL, Crawford RW, Russell JM, Bevins CL, Adams LG, Tsolis RM, Roth JR, Bäumler AJ. 2010. Gut inflammation provides a respiratory electron acceptor for salmonella. Nature 467:426-429. http://dx.doi.org/10.1038/nature09415.
38. Hruz P, Zinkernagel AS, Jenikova G, Botwin GJ, Hugot JP, Karin M, Nizet V, Eckmann L. 2009. NOD2 contributes to cutaneous defense against Staphylococcus aureus through alpha-toxin-dependent innate immune activation. Proc Natl Acad Sci U S A 106:12873-12878. http://dx.doi.org/10.1073/pnas.0904958106.
39. Ali SR, Timmer AM, Bilgrami S, Park EJ, Eckmann L, Nizet V, Karin M. 2011. Anthrax toxin induces macrophage death by p38 MAPK inhibition but leads to inflammasome activation via ATP leakage. Immunity 35: 34-44. http://dx.doi.org/10.1016/j.immuni.2011.04.015.
40. Chang YC, Uchiyama S, Varki A, Nizet V. 2012. Leukocyte inflammatory responses provoked by pneumococcal sialidase. mBio 3:e00220-11. http://dx.doi.org/10.1128/mBio.00220-11.
41. Hollands A, Pence MA, Timmer AM, Osvath SR, Turnbull L, Whitchurch CB, Walker MJ, Nizet V. 2010. Genetic switch to hypervirulence reduces colonization phenotypes of the globally disseminated group A streptococcus M1T1 clone. J Infect Dis 202:11-19. http://dx.doi.org/10.1086/653124.
42. Aziz RK, Pabst MJ, Jeng A, Kansal R, Low DE, Nizet V, Kotb M. 2004. Invasive M1T1 group A streptococcus undergoes a phase-shift in vivo to prevent proteolytic degradation of multiple virulence factors by SpeB. Mol Microbiol 51:123-134. http://dx.doi.org/10.1046/j.1365-2958.2003.03797.x.
43. Hamilton A, Robinson C, Sutcliffe IC, Slater J, Maskell DJ, Davis- Poynter N, Smith K, Waller A, Harrington DJ. 2006. Mutation of the maturase lipoprotein attenuates the virulence of Streptococcus equi to a greater extent than does loss of general lipoprotein lipidation. Infect Immun 74:6907-6919. http://dx.doi.org/10.1128/IAI.01116-06.
44. Kraemer GR, Iandolo JJ. 1990. High-frequency transformation of Staphylococcus aureus by electroporation. Curr Microbiol 21:373-376. http://dx.doi.org/10.1007/BF02199440.
45. Lin AE, Guttman JA. 2012. The Escherichia coli adherence factor plasmid of enteropathogenic Escherichia coli causes a global decrease in ubiquitylated host cell proteins by decreasing ubiquitin E1 enzyme expression through host aspartyl proteases. Int J Biochem Cell Biol 44:2223-2232. http://dx.doi.org/10.1016/j.biocel.2012.09.005.
46. Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45. http://dx.doi.org/10.1093/nar/29.9.e45.
47. Lin AE, Autran CA, Lin AE, Autran CA, Espanola SD, Bode L, Nizet V. 2013. Human milk oligosaccharides protect bladder epithelial cells against uropathogenic Escherichia coli invasion and cytotoxicity. J Infect Dis 209: 389-398. http://dx.doi.org/10.1093/infdis/jit464.
48. Timmer AM, Timmer JC, Pence MA, Hsu LC, Ghochani M, Frey TG, Karin M, Salvesen GS, Nizet V. 2009. Streptolysin O promotes group A streptococcus immune evasion by accelerated macrophage apoptosis. J Biol Chem 284:862-871. http://dx.doi.org/10.1074/jbc.M804632200.